Alzheimer’s & Brain Awareness Month in June is a time not just for reflection, but for action, writes guest columnist ...

A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in ...

Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...

Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...

A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...

A research team has, for the first time, identified at the cellular level why the olfactory system is the first to be damaged ...

A new study indicates ‘we can identify those that are susceptible to Alzheimer’s disease and give them this peptide [therapy] ...

Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood ...

A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.